---
title: "Tempus AI agrees to buy Personalis for USD 16.25 per share in USD 1.5 billion deal"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293214621.md"
description: "Tempus AI agreed to acquire Personalis in a USD 1.5 billion all-stock deal, valuing shares at USD 16.25. The transaction includes an option for up to 50% cash consideration and expands Tempus' minimal residual disease offerings through Personalis' NeXT Personal test. Closing is expected in late 2026 or early 2027, pending shareholder approval and regulatory clearances."
datetime: "2026-07-20T12:32:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293214621.md)
  - [en](https://longbridge.com/en/news/293214621.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293214621.md)
generator: "portal-rs"
---

# Tempus AI agrees to buy Personalis for USD 16.25 per share in USD 1.5 billion deal

-   Tempus AI agreed to acquire Personalis for USD 16.25 per share, valuing the deal at USD 1.5 billion net of Tempus’ existing stake. \* Consideration is 100% stock, with an option to pay up to 50% in cash at Tempus’ discretion; cash would use cash on hand and credit facilities. \* Personalis holders will receive a floating exchange ratio of Tempus Class A common stock, capped at 0.3356 per Personalis share. \* Closing is expected in late 2026 or early 2027, pending Personalis shareholder vote and regulatory clearances. \* Transaction expands Tempus’ minimal residual disease offering via Personalis’ tumor-informed NeXT Personal test; Personalis posted Q2 revenue of USD 22.4 million on 10,384 clinical tests. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempus AI Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202607200830BIZWIRE\_USPR\_\_\_\_\_20260720\_BW857328) on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [PSNL.US](https://longbridge.com/en/quote/PSNL.US.md)
- [TEM.US](https://longbridge.com/en/quote/TEM.US.md)
- [TEMT.US](https://longbridge.com/en/quote/TEMT.US.md)

## Related News & Research

- [Renaissance Technologies LLC Decreases Position in Personalis, Inc. $PSNL](https://longbridge.com/en/news/296588775.md)
- [Tempus AI (NASDAQ:TEM) CAO Ryan Bartolucci Sells 6,175 Shares of Stock](https://longbridge.com/en/news/296562025.md)
- [Andrew Polovin Sells 22,148 Shares of Tempus AI (NASDAQ:TEM) Stock](https://longbridge.com/en/news/296610788.md)
- [Green Alpha Advisors LLC Takes $904,000 Position in Personalis, Inc. $PSNL](https://longbridge.com/en/news/296676831.md)
- [Tempus AI director Nadja West disposes of 3,000 common shares worth $161,700](https://longbridge.com/en/news/296265854.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**